img

Global Assisted Reproduction Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Assisted Reproduction Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Assisted Reproduction Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Assisted Reproduction Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Down Regultion and Controlled Ovarian Hyperstimulation are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Assisted Reproduction Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Assisted Reproduction Drug key companies include Merck Serono, Merck Sharp & Dohme, Livzon Group, Zhejiang Xianju Pharmaceutical Co., Ltd., GenSci, Shanghai First Biochemical Pharmaceutical Co. LTD, Ipsen Pharma Biotech and Solvay Pharma, etc. Merck Serono, Merck Sharp & Dohme, Livzon Group are top 3 players and held % share in total in 2022.
Assisted Reproduction Drug can be divided into Gonadotropin Releasing Hormone, Follicle-stimulating Hormone, Human Choroinic Gonadotrophin and Progestogen Hormone, etc. Gonadotropin Releasing Hormone is the mainstream product in the market, accounting for % share globally in 2022.
Assisted Reproduction Drug is widely used in various fields, such as Down Regultion, Controlled Ovarian Hyperstimulation, Induced Ovulation and luteal Support, etc. Down Regultion provides greatest supports to the Assisted Reproduction Drug industry development. In 2022, global % share of Assisted Reproduction Drug went into Down Regultion filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Assisted Reproduction Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck Serono
Merck Sharp & Dohme
Livzon Group
Zhejiang Xianju Pharmaceutical Co., Ltd.
GenSci
Shanghai First Biochemical Pharmaceutical Co. LTD
Ipsen Pharma Biotech
Solvay Pharma
Segment by Type
Gonadotropin Releasing Hormone
Follicle-stimulating Hormone
Human Choroinic Gonadotrophin
Progestogen Hormone

Segment by Application


Down Regultion
Controlled Ovarian Hyperstimulation
Induced Ovulation
luteal Support
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Assisted Reproduction Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Assisted Reproduction Drug introduction, etc. Assisted Reproduction Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Assisted Reproduction Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Assisted Reproduction Drug
1.1 Assisted Reproduction Drug Market Overview
1.1.1 Assisted Reproduction Drug Product Scope
1.1.2 Assisted Reproduction Drug Market Status and Outlook
1.2 Global Assisted Reproduction Drug Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Assisted Reproduction Drug Market Size by Region (2018-2034)
1.4 Global Assisted Reproduction Drug Historic Market Size by Region (2018-2024)
1.5 Global Assisted Reproduction Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Assisted Reproduction Drug Market Size (2018-2034)
1.6.1 North America Assisted Reproduction Drug Market Size (2018-2034)
1.6.2 Europe Assisted Reproduction Drug Market Size (2018-2034)
1.6.3 Asia-Pacific Assisted Reproduction Drug Market Size (2018-2034)
1.6.4 Latin America Assisted Reproduction Drug Market Size (2018-2034)
1.6.5 Middle East & Africa Assisted Reproduction Drug Market Size (2018-2034)
2 Assisted Reproduction Drug Market by Type
2.1 Introduction
2.1.1 Gonadotropin Releasing Hormone
2.1.2 Follicle-stimulating Hormone
2.1.3 Human Choroinic Gonadotrophin
2.1.4 Progestogen Hormone
2.2 Global Assisted Reproduction Drug Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Assisted Reproduction Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Assisted Reproduction Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Assisted Reproduction Drug Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Assisted Reproduction Drug Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Assisted Reproduction Drug Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Assisted Reproduction Drug Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Assisted Reproduction Drug Revenue Breakdown by Type (2018-2034)
3 Assisted Reproduction Drug Market Overview by Application
3.1 Introduction
3.1.1 Down Regultion
3.1.2 Controlled Ovarian Hyperstimulation
3.1.3 Induced Ovulation
3.1.4 luteal Support
3.2 Global Assisted Reproduction Drug Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Assisted Reproduction Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Assisted Reproduction Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Assisted Reproduction Drug Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Assisted Reproduction Drug Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Assisted Reproduction Drug Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Assisted Reproduction Drug Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Assisted Reproduction Drug Revenue Breakdown by Application (2018-2034)
4 Assisted Reproduction Drug Competition Analysis by Players
4.1 Global Assisted Reproduction Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Assisted Reproduction Drug as of 2022)
4.3 Date of Key Players Enter into Assisted Reproduction Drug Market
4.4 Global Top Players Assisted Reproduction Drug Headquarters and Area Served
4.5 Key Players Assisted Reproduction Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Assisted Reproduction Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck Serono
5.1.1 Merck Serono Profile
5.1.2 Merck Serono Main Business
5.1.3 Merck Serono Assisted Reproduction Drug Products, Services and Solutions
5.1.4 Merck Serono Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Merck Serono Recent Developments
5.2 Merck Sharp & Dohme
5.2.1 Merck Sharp & Dohme Profile
5.2.2 Merck Sharp & Dohme Main Business
5.2.3 Merck Sharp & Dohme Assisted Reproduction Drug Products, Services and Solutions
5.2.4 Merck Sharp & Dohme Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Merck Sharp & Dohme Recent Developments
5.3 Livzon Group
5.3.1 Livzon Group Profile
5.3.2 Livzon Group Main Business
5.3.3 Livzon Group Assisted Reproduction Drug Products, Services and Solutions
5.3.4 Livzon Group Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Developments
5.4 Zhejiang Xianju Pharmaceutical Co., Ltd.
5.4.1 Zhejiang Xianju Pharmaceutical Co., Ltd. Profile
5.4.2 Zhejiang Xianju Pharmaceutical Co., Ltd. Main Business
5.4.3 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Products, Services and Solutions
5.4.4 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Developments
5.5 GenSci
5.5.1 GenSci Profile
5.5.2 GenSci Main Business
5.5.3 GenSci Assisted Reproduction Drug Products, Services and Solutions
5.5.4 GenSci Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.5.5 GenSci Recent Developments
5.6 Shanghai First Biochemical Pharmaceutical Co. LTD
5.6.1 Shanghai First Biochemical Pharmaceutical Co. LTD Profile
5.6.2 Shanghai First Biochemical Pharmaceutical Co. LTD Main Business
5.6.3 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Products, Services and Solutions
5.6.4 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Shanghai First Biochemical Pharmaceutical Co. LTD Recent Developments
5.7 Ipsen Pharma Biotech
5.7.1 Ipsen Pharma Biotech Profile
5.7.2 Ipsen Pharma Biotech Main Business
5.7.3 Ipsen Pharma Biotech Assisted Reproduction Drug Products, Services and Solutions
5.7.4 Ipsen Pharma Biotech Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Ipsen Pharma Biotech Recent Developments
5.8 Solvay Pharma
5.8.1 Solvay Pharma Profile
5.8.2 Solvay Pharma Main Business
5.8.3 Solvay Pharma Assisted Reproduction Drug Products, Services and Solutions
5.8.4 Solvay Pharma Assisted Reproduction Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Solvay Pharma Recent Developments
6 North America
6.1 North America Assisted Reproduction Drug Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Assisted Reproduction Drug Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Assisted Reproduction Drug Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Assisted Reproduction Drug Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Assisted Reproduction Drug Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Assisted Reproduction Drug Market Dynamics
11.1 Assisted Reproduction Drug Industry Trends
11.2 Assisted Reproduction Drug Market Drivers
11.3 Assisted Reproduction Drug Market Challenges
11.4 Assisted Reproduction Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Assisted Reproduction Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Assisted Reproduction Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Assisted Reproduction Drug Market Size Share by Region (2018-2024)
Table 4. Global Assisted Reproduction Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Assisted Reproduction Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Assisted Reproduction Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Assisted Reproduction Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Assisted Reproduction Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Assisted Reproduction Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Assisted Reproduction Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Assisted Reproduction Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Assisted Reproduction Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Assisted Reproduction Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Assisted Reproduction Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Assisted Reproduction Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Assisted Reproduction Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Assisted Reproduction Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Assisted Reproduction Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Assisted Reproduction Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Assisted Reproduction Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Assisted Reproduction Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Assisted Reproduction Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Assisted Reproduction Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Assisted Reproduction Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Assisted Reproduction Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Assisted Reproduction Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Assisted Reproduction Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Assisted Reproduction Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Assisted Reproduction Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Assisted Reproduction Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Assisted Reproduction Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Assisted Reproduction Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Assisted Reproduction Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Assisted Reproduction Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Assisted Reproduction Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Assisted Reproduction Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Assisted Reproduction Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Assisted Reproduction Drug as of 2022)
Table 39. Date of Key Players Enter into Assisted Reproduction Drug Market
Table 40. Global Assisted Reproduction Drug Key Players Headquarters and Area Served
Table 41. Assisted Reproduction Drug Product Solution and Service
Table 42. Global Assisted Reproduction Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck Serono Basic Information List
Table 45. Merck Serono Description and Business Overview
Table 46. Merck Serono Assisted Reproduction Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Assisted Reproduction Drug Business of Merck Serono (2018-2024)
Table 48. Merck Serono Recent Developments
Table 49. Merck Sharp & Dohme Basic Information List
Table 50. Merck Sharp & Dohme Description and Business Overview
Table 51. Merck Sharp & Dohme Assisted Reproduction Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Assisted Reproduction Drug Business of Merck Sharp & Dohme (2018-2024)
Table 53. Merck Sharp & Dohme Recent Developments
Table 54. Livzon Group Basic Information List
Table 55. Livzon Group Description and Business Overview
Table 56. Livzon Group Assisted Reproduction Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Assisted Reproduction Drug Business of Livzon Group (2018-2024)
Table 58. Livzon Group Recent Developments
Table 59. Zhejiang Xianju Pharmaceutical Co., Ltd. Basic Information List
Table 60. Zhejiang Xianju Pharmaceutical Co., Ltd. Description and Business Overview
Table 61. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Assisted Reproduction Drug Business of Zhejiang Xianju Pharmaceutical Co., Ltd. (2018-2024)
Table 63. Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Developments
Table 64. GenSci Basic Information List
Table 65. GenSci Description and Business Overview
Table 66. GenSci Assisted Reproduction Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Assisted Reproduction Drug Business of GenSci (2018-2024)
Table 68. GenSci Recent Developments
Table 69. Shanghai First Biochemical Pharmaceutical Co. LTD Basic Information List
Table 70. Shanghai First Biochemical Pharmaceutical Co. LTD Description and Business Overview
Table 71. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Assisted Reproduction Drug Business of Shanghai First Biochemical Pharmaceutical Co. LTD (2018-2024)
Table 73. Shanghai First Biochemical Pharmaceutical Co. LTD Recent Developments
Table 74. Ipsen Pharma Biotech Basic Information List
Table 75. Ipsen Pharma Biotech Description and Business Overview
Table 76. Ipsen Pharma Biotech Assisted Reproduction Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Assisted Reproduction Drug Business of Ipsen Pharma Biotech (2018-2024)
Table 78. Ipsen Pharma Biotech Recent Developments
Table 79. Solvay Pharma Basic Information List
Table 80. Solvay Pharma Description and Business Overview
Table 81. Solvay Pharma Assisted Reproduction Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Assisted Reproduction Drug Business of Solvay Pharma (2018-2024)
Table 83. Solvay Pharma Recent Developments
Table 84. North America Assisted Reproduction Drug Market Size by Country (2018-2024) & (US$ Million)
Table 85. North America Assisted Reproduction Drug Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Assisted Reproduction Drug Market Size by Country (2018-2024) & (US$ Million)
Table 87. Europe Assisted Reproduction Drug Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Assisted Reproduction Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 89. Asia-Pacific Assisted Reproduction Drug Market Size by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Assisted Reproduction Drug Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Assisted Reproduction Drug Market Share by Region (2018-2024)
Table 92. Asia-Pacific Assisted Reproduction Drug Market Share by Region (2024-2034)
Table 93. Latin America Assisted Reproduction Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 94. Latin America Assisted Reproduction Drug Market Size by Country (2018-2024) & (US$ Million)
Table 95. Latin America Assisted Reproduction Drug Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Assisted Reproduction Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 97. Middle East & Africa Assisted Reproduction Drug Market Size by Country (2018-2024) & (US$ Million)
Table 98. Middle East & Africa Assisted Reproduction Drug Market Size by Country (2024-2034) & (US$ Million)
Table 99. Assisted Reproduction Drug Market Trends
Table 100. Assisted Reproduction Drug Market Drivers
Table 101. Assisted Reproduction Drug Market Challenges
Table 102. Assisted Reproduction Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Assisted Reproduction Drug Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Assisted Reproduction Drug Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Assisted Reproduction Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Assisted Reproduction Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Assisted Reproduction Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Assisted Reproduction Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Assisted Reproduction Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Assisted Reproduction Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Assisted Reproduction Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Gonadotropin Releasing Hormone
Figure 11. Global Gonadotropin Releasing Hormone Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Follicle-stimulating Hormone
Figure 13. Global Follicle-stimulating Hormone Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Human Choroinic Gonadotrophin
Figure 15. Global Human Choroinic Gonadotrophin Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Progestogen Hormone
Figure 17. Global Progestogen Hormone Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Global Assisted Reproduction Drug Market Size Share by Type: 2022 & 2034
Figure 19. North America Assisted Reproduction Drug Revenue Market Share by Type (2018-2034)
Figure 20. Europe Assisted Reproduction Drug Revenue Market Share by Type (2018-2034)
Figure 21. Asia-Pacific Assisted Reproduction Drug Revenue Market Share by Type (2018-2034)
Figure 22. Latin America Assisted Reproduction Drug Revenue Market Share by Type (2018-2034)
Figure 23. Middle East and Africa Assisted Reproduction Drug Revenue Market Share by Type (2018-2034)
Figure 24. Down Regultion Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Controlled Ovarian Hyperstimulation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Induced Ovulation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. luteal Support Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Global Assisted Reproduction Drug Market Size Share by Application: 2022 & 2034
Figure 29. North America Assisted Reproduction Drug Revenue Market Share by Application (2018-2034)
Figure 30. Europe Assisted Reproduction Drug Revenue Market Share by Application (2018-2034)
Figure 31. Asia-Pacific Assisted Reproduction Drug Revenue Market Share by Application (2018-2034)
Figure 32. Latin America Assisted Reproduction Drug Revenue Market Share by Application (2018-2034)
Figure 33. Middle East and Africa Assisted Reproduction Drug Revenue Market Share by Application (2018-2034)
Figure 34. Assisted Reproduction Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Assisted Reproduction Drug Market Share in 2022
Figure 36. North America Assisted Reproduction Drug Market Share by Country (2018-2034)
Figure 37. U.S. Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 38. Canada Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 39. Germany Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 40. France Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 41. U.K. Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 42. Italy Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 43. Russia Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 44. Nordic Countries Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 45. Asia-Pacific Assisted Reproduction Drug Market Share by Region (2018-2034)
Figure 46. China Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 47. Japan Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 48. South Korea Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 49. Southeast Asia Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 50. India Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 51. Australia Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 52. Latin America Assisted Reproduction Drug Market Share by Country (2018-2034)
Figure 53. Mexico Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 54. Brazil Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 55. Middle East & Africa Assisted Reproduction Drug Market Share by Country (2018-2034)
Figure 56. Turkey Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 57. Saudi Arabia Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 58. UAE Assisted Reproduction Drug Market Size (2018-2034) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report